## Abstract There is some evidence suggesting that Parkinson's disease (PD) patients exhibit lower body weight when compared to ageβmatched healthy subjects. Low body mass index (BMI) is correlated with low bone mineral density, both of which are major risk factors for hip fractures. Possible deter
Increase in body weight after pramipexole treatment in Parkinson's disease
β Scribed by Hatice Kumru; Joan Santamaria; Francesc Valldeoriola; Maria J. Marti; Eduardo Tolosa
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 76 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Body weight changes occur during the clinical course of Parkinson's disease (PD) and with surgical treatment, but the effect of dopaminergic treatment on weight is unknown. Body mass index (BMI), Hamilton depression scale score (HDS), and Unified Parkinson's Disease Rating Scale III (UPRSβIII) were measured before and 3 months after starting pramipexole in 28 PD patients. Pramipexole produced a significant weight increase, as well as motor and mood improvement (P <0.001). HDS and BMI changes were mildly related (P = 0.05). A direct effect of pramipexole on limbic D~3~ receptors involved in the control of feeding may be responsible for weight gain in PD.
Β© 2006 Movement Disorder Society
π SIMILAR VOLUMES
## Abstract Weight loss is a common problem in Parkinson's disease (PD), but the causative mechanisms behind this weight loss are unclear. We compared 26 PD patients with sex and age matched healthy controls. Examinations were repeated at baseline, after one and after two years. Body fat mass was m